2 assets in Ovarian Epithelial Tumor

Therapeutic assets addressing Ovarian Epithelial Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lenvatinib Ovarian Epithelial Tumor	Sheba Medical Center	P2	CCC (53)
Pembrolizumab Ovarian Epithelial Tumor	Sheba Medical Center	P2	CCC (53)